Transcriptomic analysis of non-small-cell lung cancer (NSCLC) cell lines upon EHMT2 inhibition revealed its role in regulating the serine-glycine synthesis pathway. The gene discussed is EHMT2; the disease is non-small cell lung carcinoma.